The incidence and predictors of thromboembolic events in patients with lung cancer

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Kadlec, Bohdan ^a   Skrickova, Jana ^a   Merta, Zdenek ^a   Dusek, Ladislav ^b   Jarkovsky, Jiri ^b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; FEMALE; HUMAN; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84893843125     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/125706     Document Type: Article

References (49)

1. Trousseau A., Phlegmasia Alba Dolens 1865 London, UK Clinique Medicale de l'Hotel Dieu de Paris
2. Leclerc J., Venous Thromboembolic Disorders 1991 Philadelphia, Pa, USA Lea & Febiger
3. Nordstrom M., Lindblad B., Bergqvist D., Kjellstrom T., A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine 1992 232 2 155 160 2-s2.0-0026764834
4. Falanga A., The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment. Cancer Investigation 2009 27 1 105 115 2-s2.0-60549106062 10.1080/07357900802563028
5. Stein P. D., Beemath A., Meyers F. A., Skaf E., Sanchez J., Olson R. E., Incidence of venous thromboembolism in patients hospitalized with cancer. American Journal of Medicine 2006 119 1 60 68 2-s2.0-30944433554 10.1016/j.amjmed.2005.06.058 (Pubitemid 43117468)
6. Blom J. W., Vanderschoot J. P. M., Oostindiër M. J., Osanto S., Van Der Meer F. J. M., Rosendaal F. R., Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: Results of a record linkage study. Journal of Thrombosis and Haemostasis 2006 4 3 529 535 2-s2.0-33645996692 10.1111/j.1538-7836.2006.01804.x
7. Khorana A. A., Francis C. W., Culakova E., Kuderer N. M., Lyman G. H., Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007 110 10 2339 2346 2-s2.0-36049000503 10.1002/cncr.23062 (Pubitemid 350100757)
8. Sack G. H. Jr., Levin J., Bell W. R., Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine 1977 56 1 1 37 2-s2.0-0017347011 (Pubitemid 8029158)
9. Boccaccio C., Comoglio P. M., Genetic link between cancer and thrombosis. Journal of Clinical Oncology 2009 27 29 4827 4833 2-s2.0-70350731332 10.1200/JCO.2009.22.7199
10. Penka M., Aktivace krevního srážení u onkologicky nemocných. Vnitřní Lékař ství 1997 43 337 339
11. Varki A., Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007 110 6 1723 1729 2-s2.0-34548838824 10.1182/blood-2006-10- 053736 (Pubitemid 47443881)
12. Deitcher S. R., Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies. Seminars in Thrombosis and Hemostasis 2003 29 3 247 258 2-s2.0-0038817722 10.1055/s-2003-40963 (Pubitemid 36776187)
13. Hammond J., Kozma C., Hart J. C., Nigam S., Daskiran M., Paris A., Mackowiak J. I., Rates of venous thromboembolism among patients with major surgery for cancer. Annals of Surgical Oncology 2011 18 12 3240 3247 2-s2.0-83055188406 10.1245/s10434-011-1723-2
14. Haddad T. C., Greeno E. W., Chemotherapy induced thrombosis. Thrombosis Research 2006 118 555 568
15. Deitcher S. R., Gomes M. P. V., The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review. Cancer 2004 101 3 439 449 2-s2.0-3242773754 10.1002/cncr.20347 (Pubitemid 38970595)
16. Schafer A. I., Thrombocytosis. The New England Journal of Medicine 2004 350 1211 1219 (Pubitemid 38339365)
17. Kaushansky K., The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation 2005 115 12 3339 3347 2-s2.0-31044439372 10.1172/JCI26674 (Pubitemid 43121817)
18. Kaushansky K., On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 2005 105 11 4187 4190 2-s2.0-19344362958 10.1182/blood-2005-03-1287 (Pubitemid 40720761)
19. Schafer A. I., Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006 107 11 4214 4222 2-s2.0-33744457651 10.1182/blood-2005-08-3526 (Pubitemid 43801343)
20. Maynard G., Stein J., Preventing Hospitalacquired Venous Thromboembolism: A Guide for Effective Quality Improvement 2008 Rockville, Md, USA Agency for Healthcare Research and Quality Prepared for the Society of Hospital Medicine. AHRQ Publication No. 08-0075
21. Mate-Kole M. O., Nkrumah K., Thrombophlebitis migrans as a marker of malignancy. East African Medical Journal 1986 63 9 610 612 2-s2.0-0022782421
22. Langer F., Spath B., Haubold K., Holstein K., Marx G., Wierecky J., Brümmendorf T. H., Dierlamm J., Bokemeyer C., Eifrig B., Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Annals of Hematology 2008 87 6 451 457 2-s2.0-39349117703 10.1007/s00277-008-0446-3
23. Favaloro E. J., Diagnostic issues in thrombophilia: a laboratory scientist's view. Seminars in Thrombosis and Hemostasis 2005 31 1 11 16 (Pubitemid 40262132)
24. Widimský J., Malý J., Akutní Plicní Embolie a Žilní Trombóza. Patogeneze, Diagnostika, Léčba a Prevence. 3. Rozšířené a Přepracované Vydání 2011 Praha, Czech Republic Triton
25. Widimský J., Malý J., Eliáš P., Lang O., Franc P., Roztočil K., Doporučení diagnostiky, léčby a prevence plicní embolie. verze, Praha, 2011, http://www.kardio-cz.cz/resources/
26. Chew H. K., Davies A. M., Wun T., Harvey D., Zhou H., White R. H., The incidence of venous thromboembolism among patients with primary lung cancer. Journal of Thrombosis and Haemostasis 2008 6 4 601 608 2-s2.0-40949119807 10.1111/j.1538-7836.2008.02908.x (Pubitemid 351404927)
27. Chew H. K., Davies A. M., Wun T., Harvey D., Zhou H., White R. H., The incidence of venous thromboembolism among patients with primary lung cancer. Journal of Thrombosis and Haemostasis 2008 6 4 601 608 2-s2.0-40949119807 10.1111/j.1538-7836.2008.02908.x (Pubitemid 351404927)
28. Blom J. W., Osanto S., Rosendaal F. R., The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. Journal of Thrombosis and Haemostasis 2004 2 10 1760 1765 2-s2.0-13244250995 10.1111/j.1538-7836.2004.00928.x (Pubitemid 40192717)
29. Loreto M. F., De Martinis M., Corsi M. P., Modesti M., Ginaldi L., Coagulation and cancer: implications for diagnosis and management. Pathology and Oncology Research 2000 6 4 301 312 2-s2.0-0034470198 (Pubitemid 32167627)
30. Chew H. K., Wun T., Harvey D., Zhou H., White R. H., Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Archives of Internal Medicine 2006 166 4 458 464 2-s2.0-33644597912 10.1001/.458
31. Haas S., Venous thromboembolism in medical patients-the scope of the problem. Seminars in Thrombosis and Hemostasis 2003 29 supplement 1 17 21 (Pubitemid 38037576)
32. Alikhan R., Cohen A. T., Combe S., Samama M. M., Desjardins L., Eldor A., Janbon C., Leizorovicz A., Olsson C.-G., Turpie A. G. G., Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Archives of Internal Medicine 2004 164 9 963 968 2-s2.0-2342514219 10.1001/archinte.164.9.963 (Pubitemid 38581515)
33. Demirci N. Y., Turay Ü. Y., Ylmaz A., Erdogan Y., Biber Ç., Yücel H., Vascular events in lung cancer. Asian Pacific Journal of Cancer Prevention 2011 12 10 2685 2687
34. Blackwell K., Haroon Z., Broadwater G., Berry D., Harris L., Iglehart J. D., Dewhirst M., Greenberg C., Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. Journal of Clinical Oncology 2000 18 3 600 608 2-s2.0-0033973069 (Pubitemid 30078541)
35. Batschauer A. P. B., Figueiredo C. P., Bueno E. C., Ribeiro M. A., Dusse L. M. S., Fernandes A. P., Gomes K. B., Carvalho M. G., D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer. Annals of Oncology 2009 21 6 1267 1272 2-s2.0-77953987382 10.1093/annonc/mdp474
36. Oya M., Akiyama Y., Okuyama T., Ishikawa H., High preoperative plasma D-dimer level and short survival after curative resection in patients with colorectal cancer. Japanese Journal of Clinical Oncology 2001 31 8 388 394
37. Blackwell K., Hurwitz H., Liebérman G., Novotny W., Snyder S., Dewhirst M., Greenberg C., Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer 2004 101 1 77 82 2-s2.0-3042529038 10.1002/cncr.20336 (Pubitemid 38812425)
38. Altiay G., Ciftci A., Demir M., Kocak Z., Sut N., Tabakoglu E., Hatipoglu O. N., Caglar T., High plasma d-dimer level is associated with decreased survival in patients with lung cancer. Clinical Oncology 2007 19 7 494 498 2-s2.0-34547540188 10.1016/j.clon.2007.04.002 (Pubitemid 47181178)
39. Buccheri G., Torchio P., Ferrigno D., Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer 2003 97 12 3044 3052 2-s2.0-0038052293 10.1002/cncr.11432 (Pubitemid 36676259)
40. Taguchi O., Gabazza E. C., Yasui H., Kobayashi T., Yoshida M., Kobayashi H., Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax 1997 52 6 563 565 2-s2.0-0030754024 (Pubitemid 27298511)
41. Zecchina G., Ghio P., Bosio S., Cravino M., Camaschella C., Scagliotti G. V., Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer. Clinical Lung Cancer 2007 8 4 264 267 2-s2.0-33847345200 10.3816/CLC.2007.n.004 (Pubitemid 46333572)
42. Gabazza E. C., Taguchi O., Yamakami T., Machishi M., Ibata H., Suzuki S., Evaluating prethrombotic state in lung cancer using molecular markers. Chest 1993 103 1 196 200 2-s2.0-0027534260 (Pubitemid 23027258)
43. De Meis E., Pinheiro V. R., Zamboni M. M., Guedes M. T. S., Castilho I. A. M., Martinez M. M. K., Leda M. S. O., Silveira N. P. R., Rumjanek V. M., Levy R. A., Clotting, immune system, and venous thrombosis in lung adenocarcinoma patients: A prospective study. Cancer Investigation 2009 27 10 989 997 2-s2.0-70450210544 10.3109/07357900903124464
44. Callander N. S., Varki N., Rao L. V. M., Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992 70 5 1194 1201 2-s2.0-0026775867
45. Ornstein D. L., Zacharski L. R., Memoli V. A., Coexisting macrophage associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues. Cancer 1991 68 1061 1067
46. Sato T., Tsujino I., Ikeda D., Ieko M., Nishimura M., Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma. Thorax 2006 61 11 1009 1010 2-s2.0-33751253447 10.1136/thx.2004.031492 (Pubitemid 44787173)
47. Khorana A. A., Francis C. W., Culakova E., Lyman G. H., Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005 104 12 2822 2829 2-s2.0-29144486069 10.1002/cncr.21496 (Pubitemid 41798294)
48. Anscher M. S., Garst J., Marks L. B., Larrier N., Dunphy F., Herndon J. E. II, Clough R., Marino C., Vujaskovic Z., Zhou S., Dewhirst M. W., Shafman T. D., Crawford J., Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury. International Journal of Radiation Oncology Biology Physics 2006 66 2 477 482 2-s2.0-33748299333 10.1016/j.ijrobp.2006.05.031 (Pubitemid 44332748)
49. Yoon S., Schmassmann-Suhijar D., Zuber M., Konietzny P., Schmassmann A., Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta. Annals of Oncology 2006 17 12 1851 1852 2-s2.0-33845353863 10.1093/annonc/mdl140 (Pubitemid 44884065)